secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2023-08-25T23:59:59+00:00
Accession:  0001493152-23-030245
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell gets court approval for spin-out of BriaPro Therapeutics, effective Aug 31, 2023
--------------------------------------------------------------------------------

- Court approved spin-out of BriaPro Therapeutics with pipeline assets including Bria-TILsRx and PKCδ inhibitors.
- Effective date expected August 31, 2023; SpinCo to be ~2/3 owned by BriaCell and ~1/3 by BriaCell shareholders.
- Shareholders receive one SpinCo share and one new BriaCell share for each old share held.
- BriaCell remains listed on Nasdaq and TSX; SpinCo to be unlisted reporting issuer in Canada.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223030245/0001493152-23-030245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223030245/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-030245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer